Origami Therapeutics is Biotechnology in United States that focus on owner business. Founded in 2015. They cover business area such as owner, operator, neurological disease, small molecule kinetic conformation stabilizer, broken protein, normal function, symptom, toxic protein, a pipeline, small molecule therapeutic, neurodegenerative disease, patient, their quality, life.
2015
( 9 years old in 2024 )
Owner
-
3525 Del Mar Heights Road
Suite 938
San Diego, CA 92130
United States
Private
owneroperatorneurological diseasesmall molecule kinetic conformation stabilizerbroken proteinnormal functionsymptomtoxic proteina pipelinesmall molecule therapeuticneurodegenerative diseasepatienttheir qualitylife
* We use standard office opening hours in near Origami Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Origami Therapeutics is Biotechnology business from United States that founded in 2015 (9 years old in 2024), Origami Therapeutics business is focusing on Owner.
Origami Therapeutics headquarter office and corporate office address is located in 3525 Del Mar Heights Road Suite 938 San Diego, CA 92130 United States.
Origami Therapeutics was founded in United States.
In 2024, Origami Therapeutics is currently focus on owner sector.
Above is snippet of Google Trends for "owner" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Origami Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
